| abstract |
The present invention provides an isolated anti-human CDS 8 antibody or antigen-binding fragment thereof; It relates to nucleic acids and expression vectors encoding them. The present invention is also used for preventing and/or treating a disease selected from neurodegenerative disease, neuroinflammatory disease, inflammatory disease, autoimmune disease, metabolic disease, eye disease, age-related disease, cancer and metastasis in a subject in need thereof In order to do so, compounds that specifically compete with CD31 for CDS 8 binding. |